NY S 5107
in committeeRelates to coverage for the screening, diagnosis and treatment of autism spectrum disorder
New York · 2025-2026 Regular Session · upper
Quick answers
Did NY S 5107 pass?
Not yet. NY S 5107 is in committee as of 2026-01-07 and has not come to a final vote. Latest recorded action (2026-01-07): REFERRED TO INSURANCE
What is NY S 5107 about?
Relates to coverage for applied behavior analysis and for developmental, individual-differences, relationship-based treatment of autism spectrum disorder.
Who sponsors NY S 5107?
Pete Harckham is the primary sponsor of NY S 5107, joined by 7 cosponsors.
Description
Relates to coverage for applied behavior analysis and for developmental, individual-differences, relationship-based treatment of autism spectrum disorder.
- Introduced
- —
- Latest action
- 2026-01-07 — REFERRED TO INSURANCE
- Bill type
- bill
- Last updated
- —
Sponsors
- Pete Harckhamprimary
- Joseph P. Addabbo Jr.cosponsor
- Cordell Clearecosponsor
- Pamela Helmingcosponsor
- John Liucosponsor
- Steve Rhoadscosponsor
- Julia Salazarcosponsor
- Mark Walczykcosponsor
Committees
Not provided by source.
Action timeline
2025-02-19
REFERRED TO INSURANCE
referral-committee
2026-01-07
REFERRED TO INSURANCE
referral-committee
Versions
- S5107Compare
Documents
Votes
Not provided by source.
Related bills
- Prior session: S 7673not in this corpus
- Prior session: S 5393not in this corpus
- Companion bill: A 3896
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T05:28:30.722574Z
Inspect retained evidence for changes recorded after evidence tracking began:
Session-wide evidence can include changes to other bills:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=NY&identifier=S 5107. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
See the methodology page for data sources and limitations.